← Back to patent-cliff list
CAS 2375033-38-6
Ethyl 5-chloro-4-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-2-ethoxybenzoate
Codes: Mosapride Citrate-067
Application context (from source-drug indications)
GastritisMosapride CitrateEnteral feeding intoleranceMosapride CitrateIrritable bowel syndromeMosapride CitrateDyspepsiaMosapride CitrateConstipationMosapride Citrate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Mosapride Citrate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
4-Amino-5-chloro-2-ethoxybenzoic acid→Sodium 4-amino-2-hydroxybenzoate→Ethyl 1,3-dioxo-2-isoindolinecarboxylate→4-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)-2-hydroxybenzoic acid→1-Bromoethane→Ethyl 4-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-2-ethoxybenzoate→Ethyl 5-chloro-4-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-2-ethoxybenzoate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.